human allogenic adipose-derived mesenchymal stem cell therapy (Jiangsu Decon Biotechnology)

N/A

Report date: 2025/03/20 15:23:12

Base Information

Drug Namehuman allogenic adipose-derived mesenchymal stem cell therapy (Jiangsu Decon Biotechnology)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Adipose stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPerianal fistula
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangsu Dekang Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Dekang Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsPerianal fistula
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A